HBL Engineering, AstraZeneca Pharma and Jayant Infratech to see some action today

01 Feb 2026 Evaluate

HBL Engineering has secured order worth Rs 575 crore (Inclusive of 18% GST) from Integral Coach Factory, Chennai for supply, testing and commissioning of On-board KAVACH equipment (Ver.4.0). The said contract is to be completed within 12 months.

AstraZeneca Pharma India has received permission from the Central Drugs Standard Control Organisation, Directorate General of Health Services, Government of India to import for sale and distribution of Durvalumab Solution for Infusion 120 mg/2.4 mL and 500 mg/10 mL [Brand Name: Imfinzi] for an additional indication. Through this approval, Durvalumab in combination with fluorouracil, leucovorin, oxaliplatin and docetaxel (FLOT) chemotherapy as neoadjuvant and adjuvant treatment, followed by single-agent Durvalumab, is indicated for the treatment of adult patients with resectable gastric or gastroesophageal junction adenocarcinoma (GC/GEJC).

Jayant Infratech has secured a letter of acceptance (LoA) from Central Railway for a Railway overhead electrification contract worth around Rs 18.64 crore. The scope of the work includes the design, supply, erection testing and commissioning of 25KV, Single Phase, AC OHE works, in connection with OHE work. The contract is to be executed by January 30, 2028.

Lemon Tree Hotels’ material subsidiary -- Fleur Hotels has signed a License Deed for a Heritage Hotel at Varanasi for a term of 28 years. Pursuant to this agreement, Fleur Hotels will repair and reconstruct a Heritage Hotel comprising around 47 rooms, which will be branded as ‘Aurika Varanasi’. Strategically located right on the ghat adjoining river Ganges, the property is around 4 km from Varanasi Junction Railway Station and about 26 km from Lal Bahadur Shastri International Airport, making it easily accessible for both domestic and international travellers.

MPS’ wholly owned material subsidiary -- MPS North America LLC (MPS NA LLC), USA, has planned to acquire 100% stake in Unbound Medicine, Inc., a United States-based healthcare technology and medical information company, subject to the terms and conditions set out in the Stock Purchase Agreement and other definitive transaction documents.

DOMS Industries has secured its Board’s approval to form a 50:50 Joint Venture Company (JVC) in India with Seven SpA, a F.I.L.A. - Fabbrica Italiana Lapis Ed Affini S.p.A., Group Company to focus on backpacks, pencil cases and bags. By leveraging the collective industry and manufacturing capabilities of the company and Seven, the JVC will supply products for the benefit of the F.I.L.A. Group globally as well as support in the development of a differentiated range of products for the Indian market.

Satin Creditcare Network has raised Rs 125 crore through the allotment of 1,25,000 rated, listed, senior, secured, redeemable, taxable, non-convertible debentures (NCDs) denominated in Indian Rupees, having a face value of Rs 10,000 each. The Working Committee of Board of Directors of the company in its meeting held on January 30, 2026, has allotted the same.

Create stable, long-term investment portfolio with strong, consistent stocks.

Start Research-backed Investing ...Now. Subscribe to Sapphire

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Fiduciary-first advisory model.
As SEBI-registered IAs, we are legally and ethically bound to act in the best interests of our clients. We do not sell or distribute any financial products. This ensures our guidance is 100% unbiased and conflict-free.
Deep fundamental research + robust valuation discipline.
Built on more than 15 years of equity research, our framework combines quality assessment, intrinsic value estimation, and a sensible margin-of-safety approach.
Process—not predictions.
We don’t rely on guesswork or market timing. Instead, we focus on asset allocation, risk management, and long-term compounding.
Technology + Human Intelligence.
We believe a combination of both is essential for investing success. We constantly innovate and upgrade in-house tools, financial X-rays, and portfolio analytics so that our team of analysts and advisors are equipped with the best.
Partner with Clients.
We follow a DIWM (Do-It-With-Me) approach where we partner clients in setting goals, financial planning, educating on our investing process and share decision-enabling resources transparently with our clients who retain control on execution.

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

Investing in stocks, mutual funds, debt, and gold
Quality-at-Reasonable-Price way of investing in stocks
Constructing Direct Stock Portfolios with Core, Booster, and Amplifier stocks
A Mutual Fund Portfolio that delivers consistent out-performance and meaningful diversification (low overlap)
Periodic review and rebalancing
Clear Buy-Sell-Hold, and Position-sizing frameworks

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.